Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia

Free Radical Research
Shang-Der ChenDing-I Yang

Abstract

Sphingolipids represent a major class of lipids in which selected family members act as bioactive molecules that control diverse cellular processes, such as proliferation, differentiation, growth, senescence, migration and apoptosis. Emerging evidence reveals that sphingomyelinase/ceramide pathway plays a pivotal role in neurodegenerative diseases that involve mitochondrial dysfunction, oxidative stress and apoptosis. Minocycline, a semi-synthetic second-generation tetracycline derivative in clinical use for infection control, is also considered an effective protective agent in various neurodegenerative diseases in pre-clinical studies. Acting via multiple mechanisms, including anti-inflammatory, anti-oxidative and anti-apoptotic effects, minocycline is a desirable candidate for clinical trials in both acute brain injury as well as chronic neurodegenerative disorders. This review is focused on the anti-apoptotic and anti-oxidative mechanisms of minocycline against neurotoxicity induced by sphingomyelinase/ceramide in relation to neurodegeneration, particularly Alzheimer's disease and cerebral ischemia.

References

Apr 1, 1978·Clinical Pharmacology and Therapeutics·P A KramerS A Mercik
Jan 1, 1991·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·L M GolubB R Rifkin
Oct 1, 1969·Journal of Pharmaceutical Sciences·J L Colaizzi, P R Klink
Jan 1, 1982·Therapeutic Drug Monitoring·B A CunhaA M Ristuccia
Jul 1, 1995·The Medical Clinics of North America·N C Klein, B A Cunha
Aug 1, 1996·Neurological Research·M KubotaS Yoshida
Jun 5, 1997·Nature·K Simons, E Ikonen
Aug 22, 1997·The Journal of Biological Chemistry·A Quillet-MaryG Laurent
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·J YrjänheikkiJ Koistinaho
Jan 23, 1999·Oncogene·S Basu, R Kolesnick
Feb 11, 1999·Advances in Dental Research·M L Nelson
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·J YrjänheikkiJ Koistinaho
Aug 31, 2000·Neurobiology of Disease·J S Gill, A J Windebank
Sep 16, 2000·Biochemical Society Symposium·G Kroemer
Apr 11, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·K FuruyaJ M Hallenbeck
May 15, 2001·American Journal of Physiology. Cell Physiology·N A BourbonM Kester
Nov 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·Y DuS M Paul
Dec 1, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H BirbesL M Obeid
Mar 29, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Dong LiuMark P Mattson
May 16, 2002·The Journal of Biological Chemistry·Yusuf A Hannun, Lina M Obeid
Jun 13, 2002·Neuroreport·Ludo Van Den BoschWim Robberecht
Jul 12, 2002·Annals of Neurology·Kara L ArvinDavid M Holtzman
Mar 18, 2003·Journal of Lipid Research·Dick HoekstraSven C D van IJzendoorn
May 6, 2003·Biochemical and Biophysical Research Communications·Maria van GurpPeter Vandenabeele
Aug 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xin WangRobert M Friedlander
Aug 23, 2003·The British Journal of Dermatology·M L Good, D L Hussey
Feb 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Roy G CutlerMark P Mattson
Mar 6, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David P StirlingWolfram Tetzlaff
Mar 9, 2004·The Journal of Biological Chemistry·Jinzhao WangZheng Dong
May 26, 2004·Biochemical Society Transactions·D Scheel-ToellnerJ M Lord
Jun 8, 2004·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Kenzo TakahashiJohn M Hallenbeck
Jul 6, 2004·Neurochemistry International·Shinji SoedaHiroshi Shimeno
Aug 3, 2004·Science·Douglas R Green, Guido Kroemer

❮ Previous
Next ❯

Citations

Jun 20, 2015·Oxidative Medicine and Cellular Longevity·Maja Jazvinšćak JembrekGoran Šimić
Dec 4, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Radhi M Yagnik, Kenza E Benzeroual
Oct 30, 2014·International Journal of Molecular Medicine·Fengshan XieLiying Qiu
Feb 5, 2014·Experimental Neurology·Thomas SchmitzStefanie Endesfelder
Jun 14, 2016·Cell Biochemistry and Function·Elena SignorettoFlorian Lang
Dec 16, 2017·Journal of Biochemical and Molecular Toxicology·Hanaa A MansourGehan S Georgy
Sep 24, 2020·Experimental Biology and Medicine·Raven A HardyHyacinth I Hyacinth
Jun 21, 2012·Free Radical Research·Hideyuki J Majima, Shinya Toyokuni
Nov 14, 2019·Neural Regeneration Research·Yazdan NaderiAmirhosein Sahebkar
Jul 24, 2018·Frontiers in Microbiology·Abhishek K VermaAnirban Basu
Nov 10, 2020·Neuroscience Letters·Xiaochen SongNing Xie
Jul 17, 2019·Journal of Proteome Research·Hsi-Chun ChaoSung-Chun Tang
Aug 10, 2019·ACS Applied Materials & Interfaces·Ting ZhangJinglin Fu
Sep 3, 2021·Molecular and Cellular Biochemistry·Puneet K SamaiyaAshok Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.